The Patent Finder

Centogene AG

Also on record
Records under this name other than the patents Centogene AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 10 of 10 · Back to Centogene AG

PatentTitleStatus Expires Confidence
US 9,910,033Method for the diagnosis of Niemann-Pick disease
Lapsed on the fee record
Ended Mar 6, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 6, 2026From the USPTO record
US 11,231,412Method for the diagnosis of Niemann-Pick disease
Lapsed on the fee record
Ended Jan 25, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 25, 2026From the USPTO record
US 11,204,357Method for the diagnosis of Farber's disease
Lapsed on the fee record
Ended Dec 21, 2025 · From the USPTO record
Lapsed on the fee recordEnded Dec 21, 2025From the USPTO record
US 11,092,609Method for the diagnosis of Gaucher's disease
Lapsed on the fee record
Ended Aug 17, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 17, 2025From the USPTO record
US 9,724,331Use of maleimide derivatives for preventing and treating leukemia
Lapsed on the fee record
Ended Aug 8, 2025 · From the USPTO record
Lapsed on the fee recordEnded Aug 8, 2025From the USPTO record
US 10,859,580Method for the diagnosis of Gaucher's disease
Lapsed on the fee record
Ended Dec 8, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 8, 2024From the USPTO record
US 10,690,682Method for the diagnosis of metachromatic leukodystrophy
Lapsed on the fee record
Ended Jun 23, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 23, 2024From the USPTO record
US 10,420,754Use of maleimide derivatives for preventing and treating cancer
Lapsed on the fee record
Ended Sep 24, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 24, 2023From the USPTO record
US 10,302,664Method for the diagnosis of Niemann-Pick disease
Lapsed on the fee record
Ended May 28, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 28, 2023From the USPTO record
US 9,993,463Use of maleimide derivatives for preventing and treating cancer
Lapsed on the fee record
Ended Jun 12, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jun 12, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited